Matches in SemOpenAlex for { <https://semopenalex.org/work/W1844989935> ?p ?o ?g. }
- W1844989935 abstract "Background Sevoflurane is an inhaled volatile anaesthetic that is widely used in paediatric anaesthetic practice. Since its introduction, postoperative behavioural disturbance known as emergence agitation (EA) or emergence delirium (ED) has been recognized as a problem that may occur during recovery from sevoflurane anaesthesia. For the purpose of this systematic review, EA has been used to describe this clinical entity. A child with EA may be restless, may cause self‐injury or may disrupt the dressing, surgical site or indwelling devices, leading to the potential for parents to be dissatisfied with their child's anaesthetic. To prevent such outcomes, the child may require pharmacological or physical restraint. Sevoflurane may be a major contributing factor in the development of EA. Therefore, an evidence‐based understanding of the risk/benefit profile regarding sevoflurane compared with other general anaesthetic agents and adjuncts would facilitate its rational and optimal use. Objectives To compare sevoflurane with other general anaesthetic (GA) agents, with or without pharmacological or non‐pharmacological adjuncts, with regard to risk of EA in children during emergence from anaesthesia. The primary outcome was risk of EA; secondary outcome was agitation score. Search methods We searched the following databases from the date of inception to 19 January 2013: CENTRAL, Ovid MEDLINE, Ovid EMBASE, the Cumulative Index to Nursing and Allied Health Literature (CINAHL) (EBSCOhost), Evidence‐Based Medicine Reviews (EBMR) and the Web of Science, as well as the reference lists of other relevant articles and online trial registers. Selection criteria We included all randomized (or quasi‐randomized) controlled trials investigating children < 18 years of age presenting for general anaesthesia with or without surgical intervention. We included any study in which a sevoflurane anaesthetic was compared with any other GA, and any study in which researchers investigated adjuncts (pharmacological or non‐pharmacological) to sevoflurane anaesthesia compared with no adjunct or placebo. Data collection and analysis Two review authors independently searched the databases, decided on inclusion eligibility of publications, ascertained study quality and extracted data. They then resolved differences between their results by discussion. Data were entered into RevMan 5.2 for analyses and presentation. Comparisons of the risk of EA were presented as risk ratios (RRs) with 95% confidence intervals (CIs). Sevoflurane is treated as the control anaesthesia in this review. Sensitivity analyses were performed as appropriate, to exclude studies with a high risk of bias and to investigate heterogeneity. Main results We included 158 studies involving 14,045 children. Interventions to prevent EA fell into two broad groups. First, alternative GA compared with sevoflurane anaesthesia (69 studies), and second, use of an adjunct with sevoflurane anaesthesia versus sevoflurane without an adjunct (100 studies). The overall risk of bias in included studies was low. The overall Grades of Recommendation, Assessment, Development and Evaluation Working Group (GRADE) assessment of the quality of the evidence was moderate to high. A wide range of EA scales were used, as were different levels of cutoff, to determine the presence or absence of EA. Some studies involved children receiving potentially inadequate or no analgesia intraoperatively during painful procedures. Halothane (RR 0.51, 95% CI 0.41 to 0.63, 3534 participants, high quality of evidence) and propofol anaesthesia were associated with a lower risk of EA than sevoflurane anaesthesia. Propofol was effective when used throughout anaesthesia (RR 0.35, 95% CI 0.25 to 0.51, 1098 participants, high quality of evidence) and when used only during the maintenance phase of anaesthesia after sevoflurane induction (RR 0.59, 95% CI 0.46 to 0.76, 738 participants, high quality of evidence). No clear evidence was found of an effect on risk of EA of desflurane (RR 1.46, 95% CI 0.92 to 2.31, 408 participants, moderate quality of evidence) or isoflurane (RR 0.76, 95% CI 0.46 to 1.23, 379 participants, moderate quality of evidence) versus sevoflurane. Compared with no adjunct, effective adjuncts for reducing the risk of EA during sevoflurane anaesthesia included dexmedetomidine (RR 0.37, 95% CI 0.29 to 0.47, 851 participants, high quality of evidence), clonidine (RR 0.45, 95% CI 0.31 to 0.66, 739 participants, high quality of evidence), opioids, in particular fentanyl (RR 0.37, 95% CI 0.27 to 0.50, 1247 participants, high quality of evidence) and a bolus of propofol (RR 0.58, 95% CI 0.38 to 0.89, 394 participants, moderate quality of evidence), ketamine (RR 0.30, 95% CI 0.13 to 0.69, 231 participants, moderate quality of evidence) or midazolam (RR 0.57, 95% CI 0.41 to 0.81, 116 participants, moderate quality of evidence) at the end of anaesthesia. Midazolam oral premedication (RR 0.81, 95% CI 0.59 to 1.12, 370 participants, moderate quality of evidence) and parental presence at emergence (RR 0.91, 95% CI 0.51 to 1.60, 180 participants, moderate quality of evidence) did not reduce the risk of EA. One or more factors designated as high risk of bias were noted in less than 10% of the included studies. Sensitivity analyses of these studies showed no clinically relevant changes in the risk of EA. Heterogeneity was significant with respect to these comparisons: halothane; clonidine; fentanyl; midazolam premedication; propofol 1 mg/kg bolus at end; and ketamine 0.25 mg/kg bolus at end of anaesthesia. With investigation of heterogeneity, the only clinically relevant changes to findings were seen in the context of potential pain, namely, the setting of adenoidectomy/adenotonsillectomy (propofol bolus; midazolam premedication) and the absence of a regional block (clonidine). Authors' conclusions Propofol, halothane, alpha‐2 agonists (dexmedetomidine, clonidine), opioids (e.g. fentanyl) and ketamine reduce the risk of EA compared with sevoflurane anaesthesia, whereas no clear evidence shows an effect for desflurane, isoflurane, midazolam premedication and parental presence at emergence. Therefore anaesthetists can consider several effective strategies to reduce the risk of EA in their clinical practice. Future studies should ensure adequate analgesia in the control group, for which pain may be a contributing or confounding factor in the diagnosis of EA. Regardless of the EA scale used, it would be helpful for study authors to report the risk of EA, so that this might be included in future meta‐analyses. Researchers should also consider combining effective interventions as a multi‐modal approach to further reduce the risk of EA." @default.
- W1844989935 created "2016-06-24" @default.
- W1844989935 creator A5000158913 @default.
- W1844989935 creator A5003954978 @default.
- W1844989935 creator A5004603092 @default.
- W1844989935 creator A5036072158 @default.
- W1844989935 creator A5049949233 @default.
- W1844989935 creator A5051873665 @default.
- W1844989935 creator A5069581823 @default.
- W1844989935 creator A5081673552 @default.
- W1844989935 creator A5090432353 @default.
- W1844989935 creator A5073060516 @default.
- W1844989935 date "2014-09-12" @default.
- W1844989935 modified "2023-10-03" @default.
- W1844989935 title "Effects of sevoflurane versus other general anaesthesia on emergence agitation in children" @default.
- W1844989935 cites W105498287 @default.
- W1844989935 cites W112427433 @default.
- W1844989935 cites W124948313 @default.
- W1844989935 cites W137327397 @default.
- W1844989935 cites W1488705246 @default.
- W1844989935 cites W1489582545 @default.
- W1844989935 cites W1497082223 @default.
- W1844989935 cites W1501742126 @default.
- W1844989935 cites W1508293915 @default.
- W1844989935 cites W1512480940 @default.
- W1844989935 cites W1526267291 @default.
- W1844989935 cites W1561790684 @default.
- W1844989935 cites W1562386314 @default.
- W1844989935 cites W1576970722 @default.
- W1844989935 cites W1596750399 @default.
- W1844989935 cites W1637632233 @default.
- W1844989935 cites W1693319652 @default.
- W1844989935 cites W1879003858 @default.
- W1844989935 cites W1923695179 @default.
- W1844989935 cites W1959414552 @default.
- W1844989935 cites W1965768243 @default.
- W1844989935 cites W1965863387 @default.
- W1844989935 cites W1966654706 @default.
- W1844989935 cites W1968874728 @default.
- W1844989935 cites W1968949916 @default.
- W1844989935 cites W1970677493 @default.
- W1844989935 cites W1970787819 @default.
- W1844989935 cites W1971112664 @default.
- W1844989935 cites W1972810690 @default.
- W1844989935 cites W1973854659 @default.
- W1844989935 cites W1975003994 @default.
- W1844989935 cites W1975264941 @default.
- W1844989935 cites W1976412078 @default.
- W1844989935 cites W1980621921 @default.
- W1844989935 cites W1981208034 @default.
- W1844989935 cites W1981461489 @default.
- W1844989935 cites W1981962644 @default.
- W1844989935 cites W1981972337 @default.
- W1844989935 cites W1985191817 @default.
- W1844989935 cites W1987437717 @default.
- W1844989935 cites W1987635953 @default.
- W1844989935 cites W1988297736 @default.
- W1844989935 cites W1990501849 @default.
- W1844989935 cites W1993697044 @default.
- W1844989935 cites W1994542202 @default.
- W1844989935 cites W1994582448 @default.
- W1844989935 cites W1994609199 @default.
- W1844989935 cites W1996274869 @default.
- W1844989935 cites W1999235751 @default.
- W1844989935 cites W2000640734 @default.
- W1844989935 cites W2001127593 @default.
- W1844989935 cites W2002533602 @default.
- W1844989935 cites W2005303049 @default.
- W1844989935 cites W2005535916 @default.
- W1844989935 cites W2006157695 @default.
- W1844989935 cites W2007093242 @default.
- W1844989935 cites W2011694298 @default.
- W1844989935 cites W2013950974 @default.
- W1844989935 cites W2013997085 @default.
- W1844989935 cites W2015459026 @default.
- W1844989935 cites W2016268075 @default.
- W1844989935 cites W2019011258 @default.
- W1844989935 cites W2019483703 @default.
- W1844989935 cites W2019875891 @default.
- W1844989935 cites W2020417283 @default.
- W1844989935 cites W2020438720 @default.
- W1844989935 cites W2020898025 @default.
- W1844989935 cites W2020988012 @default.
- W1844989935 cites W2022026276 @default.
- W1844989935 cites W2022994728 @default.
- W1844989935 cites W2024960397 @default.
- W1844989935 cites W2028622447 @default.
- W1844989935 cites W2029166714 @default.
- W1844989935 cites W2029392798 @default.
- W1844989935 cites W2029617764 @default.
- W1844989935 cites W2031485270 @default.
- W1844989935 cites W2031677125 @default.
- W1844989935 cites W2031860945 @default.
- W1844989935 cites W2031941946 @default.
- W1844989935 cites W2036298452 @default.
- W1844989935 cites W2038505504 @default.
- W1844989935 cites W2039225685 @default.
- W1844989935 cites W2042843181 @default.
- W1844989935 cites W2047256587 @default.
- W1844989935 cites W2049156521 @default.